It has been proposed that over secretion of PTH in patients with PHPT is, among others, produced by an alteration of the CaSR set-point [28–30], being the immunohistochemical expression of the CaSR and CaSR mRNA expression reduced in parathyroid adenomas [29–31]. This evidence concerns the gene CASR and parathyroid gland adenoma.